CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.

[1]  F. Emmrich,et al.  Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process. , 1995, Transplantation proceedings.

[2]  A. O'Rourke,et al.  The roles of CD8 in cytotoxic T lymphocyte function. , 1993, Immunology today.

[3]  C. Maroun,et al.  Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signalling. , 1993, Immunology today.

[4]  K. Wood,et al.  THE ASSESSMENT OF TRANSPLANTATION TOLERANCE INDUCED BY ANTI‐CD4 MONOCLONAL ANTIBODY IN THE MURINE MODEL1 , 1993, Transplantation.

[5]  H. Volk,et al.  INDUCTION OF LONG‐TERM SURVIVAL OF RAT SKIN ALLOGRAFTS BY A NOVEL, HIGHLY EFFICIENT ANTI‐CD4 MONOCLONAL ANTIBODY , 1992, Transplantation.

[6]  G. Opelz.  Collaborative Transplant Study--10-year report. , 1992, Transplantation proceedings.

[7]  J. Madsen,et al.  INDUCTION OF TRANSPLANTATION TOLERANCE IN ADULTS USING DONOR ANTIGEN AND ANTI‐CD4 MONOCLONAL ANTIBODY , 1992, Transplantation.

[8]  F. Emmrich,et al.  Anti-CD4 therapy of acute rejection in long-term renal allograft recipients , 1991, The Lancet.

[9]  J. Chapman,et al.  Survival of DNA HLA-DR typed and matched cadaver kidney transplants , 1991, The Lancet.

[10]  T. Sablinski,et al.  Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. , 1991, Transplantation.

[11]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[12]  V. Starnes,et al.  INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI‐CD4 MONOCLONAL ANTIBODY THERAPY , 1990, Transplantation.

[13]  M. Giral,et al.  Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. , 1990, The New England journal of medicine.

[14]  R. Perlmutter,et al.  Interaction of the unique N-terminal region of tyrosine kinase p56 lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs , 1990, Cell.

[15]  T. Waldmann,et al.  Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  E. Reinherz,et al.  Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding , 1989, Nature.

[17]  C. Fathman,et al.  CARDIAC ALLOGRAFT PROLONGATION IN MICE TREATED WITH COMBINED POSTTRANSPLANTATION TOTAL‐LYMPHOID IRRADIATION AND ANTI‐L3T4 ANTIBODY THERAPY , 1989, Transplantation.

[18]  L. Samelson,et al.  Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck , 1989, Nature.

[19]  H. Waldmann,et al.  Manipulation of T-cell responses with monoclonal antibodies. , 1989, Annual review of immunology.

[20]  B. Roser,et al.  STRATEGIES OF MONOCLONAL ANTIBODY THERAPY THAT INDUCE PERMANENT TOLERANCE OF ORGAN TRANSPLANTS , 1988, Transplantation.

[21]  D. Kaufman,et al.  USE OF ANTI‐L3T4 AND ANTI‐Ia TREATMENTS FOR PROLONGATION OF XENOGENEIC ISLET TRANSPLANTS , 1988, Transplantation.

[22]  B. Seed,et al.  Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4 , 1988, Cell.

[23]  C. Rudd,et al.  The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Fathman,et al.  Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. , 1988, Science.

[25]  D. Niederwieser,et al.  IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. , 1988, Journal of immunology.

[26]  W. Knapp,et al.  MONOCLONAL ANTI-CD4 IN ARTHRITIS , 1987, The Lancet.

[27]  J. Madsen,et al.  The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. , 1987, Transplantation.

[28]  J. Strominger,et al.  Interaction between CD4 and class II MHC molecules mediates cell adhesion , 1987, Nature.

[29]  C. Fathman,et al.  Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. , 1987, Science.

[30]  W. Seaman,et al.  Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.

[31]  R. Klausner,et al.  Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor , 1986, Cell.

[32]  C. Fathman,et al.  Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4 , 1986, The Journal of experimental medicine.

[33]  O. Majdic,et al.  Analysis of CD3-antibody-mediated inhibition of T-cell activation. , 1986, Cellular immunology.

[34]  H. Waldmann,et al.  Induction of tolerance by monoclonal antibody therapy , 1986, Nature.

[35]  I. Bernstein,et al.  Leukocyte Typing II , 1986, Springer New York.

[36]  L. Chess,et al.  Perturbation of the T4 molecule transmits a negative signal to T cells , 1985, The Journal of experimental medicine.

[37]  W. Seaman,et al.  Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4: studies with soluble antigens in intact mice. , 1985, Journal of immunology.

[38]  S. Sriram,et al.  Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 , 1985, The Journal of experimental medicine.

[39]  P. Neuhaus,et al.  OKT4 AND OKT4A ANTIBODY TREATMENT AS IMMUNOSUPPRESSION FOR KIDNEY TRANSPLANTATION IN RHESUS MONKEYS , 1985, Transplantation.

[40]  M. Waldor,et al.  Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. , 1985, Science.

[41]  R. Rubin,et al.  EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTION , 1984, Transplantation.

[42]  L. Chess,et al.  The T4 surface antigen is involved in the induction of helper function. , 1984, Journal of immunology.

[43]  G. Danovitch,et al.  Renal transplantation update. , 1984, Annals of internal medicine.

[44]  P. Marrack,et al.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. , 1983, Journal of immunology.

[45]  K. A. Wall,et al.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.

[46]  W. Biddison,et al.  Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens. , 1983, Diagnostic immunology.

[47]  R. Colvin,et al.  Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. , 1981, The New England journal of medicine.

[48]  R. Filo,et al.  THERAPY OF ACUTE CADAVERIC RENAL ALLOGRAFT REJECTION WITH ADJUNCTIVE ANTITHYMOCYTE GLOBULIN , 1980, Transplantation.

[49]  C. Huber,et al.  Linear density gradient separation of human lymphocyte subsets , 1977, European journal of immunology.